Live Model Portfolio

Titan Gems

The names our ethical framework flagged before the crowd — each with the date we called it, the financials and ethics behind it, the upside we see, and the live result since. Not a tip sheet. A dated, honest record you can watch unfold.

Updated 2026-07-21 · Analysis, not financial advice.

Case Studies — real, dated positions

Live positions we entered and are tracking to the day.

DLO · dLocal Limited ✓ Ethical PASS
distribution · STRONG OPPORTUNITY · $4.26bn
flagged 2026-07-01 @ $12.25
now $14.77   +20.6%

Upside

Target range
$14.5 – $21.0 (avg $18.0)
Implied +21.9% to average
Our fair value $21.0 · 45% discount

Financials

Revenue growth 54.9%
Fwd P/E 12.8
Profit margin 15.8%
Debt/Equity 19.8

Ethics

Business activity
Debt ratio
Liquidity
Receivables
Revenue purity
Why it makes the list

It trades at a 45% discount to our $21.00 fair value, strong competitive moat, 55% revenue growth, and clears all 5 of our ethical screens. Full analysis →

CRMD · CorMedix Inc. ✓ Ethical PASS
accumulation · STRONG OPPORTUNITY · $0.66bn
flagged 2026-07-01 @ $8.36
now $8.19   -2.0%

Upside

Target range
$13.0 – $19.0 (avg $15.0)
Implied +83.2% to average
Our fair value $11.4 · 35% discount

Financials

Revenue growth 226%
Fwd P/E 24.1
Profit margin 45.2%
Debt/Equity 33.7

Ethics

Business activity
Debt ratio
Liquidity
Receivables
Revenue purity
Why it makes the list

It trades at a 35% discount to our $11.35 fair value, strong competitive moat, 226% revenue growth, and clears all 5 of our ethical screens. Full analysis →

Hidden Gems — small-caps our screens rate now

Sub-$1bn names, ethically clean, flagged at today's price.

GAU · Galiano Gold Inc. ✓ Ethical PASS
markdown · OPPORTUNITY · $0.45bn
flagged 2026-07-18 @ $1.72
now $1.85   +7.6%

Upside

Target range
$4.3 – $4.3 (avg $4.3)
Implied +129.7% to average
Our fair value $2.3 · 35% discount

Financials

Revenue growth 249%
Fwd P/E 1.9
Profit margin 7.0%
Debt/Equity 12.4

Ethics

Business activity
Debt ratio
Liquidity
Receivables
Revenue purity
Why it makes the list

It trades at a 35% discount to our $2.32 fair value, weak competitive moat, 249% revenue growth, and clears all 5 of our ethical screens. Full analysis →

KMDA · Kamada Ltd. ✓ Ethical PASS
distribution · OPPORTUNITY · $0.41bn
flagged 2026-07-18 @ $7.05
now $7.28   +3.3%

Upside

Target range
$11.0 – $15.0 (avg $13.0)
Implied +78.6% to average
Our fair value $13.3 · 88% discount

Financials

Revenue growth 2.8%
Fwd P/E 11.5
Profit margin 11.2%
Debt/Equity 4.5

Ethics

Business activity
Debt ratio
Liquidity
Receivables
Revenue purity
Why it makes the list

It trades at a 88% discount to our $13.25 fair value, weak competitive moat, 3% revenue growth, and clears all 5 of our ethical screens. Full analysis →

ETON · Eton Pharmaceuticals, Inc. ✓ Ethical PASS
markup · OPPORTUNITY · $1.16bn
flagged 2026-07-18 @ $42.32
now $43.20   +2.1%

Upside

Target range
$40.0 – $60.0 (avg $48.5)
Implied +12.3% to average
Our fair value $44.9 · 6% discount

Financials

Revenue growth 40.4%
Fwd P/E 22.5
Profit margin -1.7%
Debt/Equity 102

Ethics

Business activity
Debt ratio
Liquidity
Receivables
Revenue purity
Why it makes the list

It trades at a 6% discount to our $44.93 fair value, weak competitive moat, 40% revenue growth, and clears all 5 of our ethical screens. Full analysis →

EPSN · Epsilon Energy Ltd. ✓ Ethical PASS
markup · OPPORTUNITY · $0.17bn
flagged 2026-07-18 @ $5.52
now $5.63   +2.0%

Upside

Limited analyst coverage — see full analysis.

Financials

Revenue growth 58.4%
Fwd P/E 14.9
Profit margin -14.9%
Debt/Equity 37.1

Ethics

Business activity
Debt ratio
Liquidity
Receivables
Revenue purity
Why it makes the list

It weak competitive moat, 58% revenue growth, and clears all 5 of our ethical screens. Full analysis →

CURI · CuriosityStream Inc. ✓ Ethical PASS
distribution · OPPORTUNITY · $0.15bn
flagged 2026-07-18 @ $2.56
now $2.59   +1.2%

Upside

Target range
$5.0 – $6.0 (avg $5.0)
Implied +93.1% to average
Our fair value $3.6 · 40% discount

Financials

Revenue growth 0.5%
Fwd P/E 10.7
Profit margin -11.3%
Debt/Equity 10.4

Ethics

Business activity
Debt ratio
Liquidity
Receivables
Revenue purity
Why it makes the list

It trades at a 40% discount to our $3.58 fair value, weak competitive moat, 1% revenue growth, and clears all 5 of our ethical screens. Full analysis →

KGEI · Kolibri Global Energy Inc. ✓ Ethical PASS
markup · OPPORTUNITY · $0.19bn
flagged 2026-07-18 @ $5.23
now $5.24   +0.2%

Upside

Target range
$8.0 – $8.0 (avg $8.0)
Implied +52.7% to average
Our fair value $6.7 · 28% discount

Financials

Revenue growth 19.5%
Fwd P/E 8.2
Profit margin 22.7%
Debt/Equity 23.7

Ethics

Business activity
Debt ratio
Liquidity
Receivables
Revenue purity
Why it makes the list

It trades at a 28% discount to our $6.70 fair value, weak competitive moat, 20% revenue growth, and clears all 5 of our ethical screens. Full analysis →

LIEN · Chicago Atlantic BDC, Inc. ✓ Ethical PASS
markup · STRONG OPPORTUNITY · $0.22bn
flagged 2026-07-18 @ $9.73
now $9.65   -0.8%

Upside

Target range
$11.0 – $11.0 (avg $11.0)
Implied +14.0% to average
Our fair value $11.0 · 13% discount

Financials

Revenue growth 40.1%
Fwd P/E 5.8
Profit margin 57.9%
Debt/Equity 17.9

Ethics

Business activity
Debt ratio
Liquidity
Receivables
Revenue purity
Why it makes the list

It trades at a 13% discount to our $11.00 fair value, moderate competitive moat, 40% revenue growth, and clears all 5 of our ethical screens. Full analysis →

ABUS · Arbutus Biopharma Corporation ✓ Ethical PASS
accumulation · OPPORTUNITY · $0.90bn
flagged 2026-07-18 @ $4.56
now $4.52   -0.9%

Upside

Target range
$4.9 – $5.5 (avg $5.2)
Implied +14.8% to average
Our fair value $5.2 · 14% discount

Financials

Revenue growth 10,055%
Fwd P/E -27.6
Profit margin 84.0%
Debt/Equity 1.5

Ethics

Business activity
Debt ratio
Liquidity
Receivables
Revenue purity
Why it makes the list

It trades at a 14% discount to our $5.19 fair value, 10,055% revenue growth, and clears all 5 of our ethical screens. Full analysis →

FENC · Fennec Pharmaceuticals Inc. ✓ Ethical PASS
markup · OPPORTUNITY · $0.36bn
flagged 2026-07-18 @ $10.50
now $10.39   -1.0%

Upside

Target range
$13.0 – $18.0 (avg $16.0)
Implied +54.0% to average
Our fair value $17.8 · 69% discount

Financials

Revenue growth 72.6%
Fwd P/E 11.8
Profit margin -16.4%
Debt/Equity

Ethics

Business activity
Debt ratio
Liquidity
Receivables
Revenue purity
Why it makes the list

It trades at a 69% discount to our $17.79 fair value, weak competitive moat, 73% revenue growth, and clears all 5 of our ethical screens. Full analysis →

NEXN · Nexxen International Ltd. ✓ Ethical PASS
accumulation · OPPORTUNITY · $0.57bn
flagged 2026-07-18 @ $10.16
now $9.96   -2.0%

Upside

Target range
$10.0 – $25.4 (avg $11.0)
Implied +10.4% to average
Our fair value $13.8 · 35% discount

Financials

Revenue growth 10.9%
Fwd P/E 8.2
Profit margin 4.8%
Debt/Equity 6.4

Ethics

Business activity
Debt ratio
Liquidity
Receivables
Revenue purity
Why it makes the list

It trades at a 35% discount to our $13.75 fair value, weak competitive moat, 11% revenue growth, and clears all 5 of our ethical screens. Full analysis →

LWAY · Lifeway Foods, Inc. ✓ Ethical PASS
distribution · OPPORTUNITY · $0.49bn
flagged 2026-07-18 @ $31.95
now $31.00   -3.0%

Upside

Target range
$34.0 – $35.0 (avg $34.5)
Implied +11.3% to average
Our fair value $31.0

Financials

Revenue growth 36.7%
Fwd P/E 23.3
Profit margin 6.5%
Debt/Equity 8.3

Ethics

Business activity
Debt ratio
Liquidity
Receivables
Revenue purity
Why it makes the list

It moderate competitive moat, 37% revenue growth, and clears all 5 of our ethical screens. Full analysis →

AMPG · AmpliTech Group, Inc. ✓ Ethical PASS
markup · OPPORTUNITY · $0.17bn
flagged 2026-07-18 @ $6.64
now $6.09   -8.3%

Upside

Target range
$7.0 – $7.0 (avg $7.0)
Implied +14.9% to average
Our fair value $7.0 · 5% discount

Financials

Revenue growth 48.6%
Fwd P/E 12.3
Profit margin -24.8%
Debt/Equity 8.4

Ethics

Business activity
Debt ratio
Liquidity
Receivables
Revenue purity
Why it makes the list

It trades at a 5% discount to our $7.00 fair value, weak competitive moat, 49% revenue growth, and clears all 5 of our ethical screens. Full analysis →

GNSS · Genasys Inc. ✓ Ethical PASS
accumulation · OPPORTUNITY · $0.08bn
flagged 2026-07-18 @ $1.72
now $1.72   0.0%

Upside

Target range
$4.0 – $6.0 (avg $4.5)
Implied +161.6% to average
Our fair value $3.4 · 100% discount

Financials

Revenue growth 124%
Fwd P/E 12.7
Profit margin -13.4%
Debt/Equity 574

Ethics

Business activity
Debt ratio
Liquidity
Receivables
Revenue purity
Why it makes the list

It trades at a 100% discount to our $3.44 fair value, weak competitive moat, 124% revenue growth, and clears all 5 of our ethical screens. Full analysis →

HIT · Health In Tech, Inc. ✓ Ethical PASS
markdown · OPPORTUNITY · $0.07bn
flagged 2026-07-18 @ $1.13
now $1.13   0.0%

Upside

Target range
$4.0 – $4.1 (avg $4.0)
Implied +254.0% to average
Our fair value $1.7 · 52% discount

Financials

Revenue growth 9.4%
Fwd P/E 7.9
Profit margin -2.4%
Debt/Equity 0.6

Ethics

Business activity
Debt ratio
Liquidity
Receivables
Revenue purity
Why it makes the list

It trades at a 52% discount to our $1.71 fair value, weak competitive moat, 9% revenue growth, and clears all 5 of our ethical screens. Full analysis →

Watch the gems the crowd hasn't found yet

Members build and monitor their own portfolio from these, each position carrying our ethical verdict and framework read.

Join Titan Protect

Titan Gems is a model portfolio for illustration and analysis. It is not financial advice, not a recommendation to buy or sell, and not a personalised portfolio. Target ranges reflect third-party analyst estimates; our fair value and ethical screening reflect our own methodology. "Flagged" dates and prices are recorded when a name enters the list and are never edited. Past performance does not guarantee future results. Always do your own research and manage your risk.

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry Indicators Options Calendar Composites Boycott Tracker Convergence Screener Fed Tracker Explore All Is It Halal? Earnings Calendar Dividend Screener Country Guides Glossary Join Free →

Get our weekly market brief free.